Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
公司代碼TDACU
公司Translational Development Acquisition Corp
CEOHoffman (Michael B)
網址
常見問題
Translational Development Acquisition Corp(TDACU)的當前股價是多少?
Translational Development Acquisition Corp(TDACU)的當前股價是 11.000。
Translational Development Acquisition Corp 的股票代碼是什麼?
Translational Development Acquisition Corp的股票代碼是TDACU。
Translational Development Acquisition Corp股票的52週最高點是多少?
Translational Development Acquisition Corp股票的52週最高點是10.900。
Translational Development Acquisition Corp股票的52週最低點是多少?
Translational Development Acquisition Corp股票的52週最低點是10.000。
Translational Development Acquisition Corp的市值是多少?
Translational Development Acquisition Corp的市值是--。
Translational Development Acquisition Corp的淨利潤是多少?
Translational Development Acquisition Corp的淨利潤為-485.55K。
現在Translational Development Acquisition Corp(TDACU)的股票是買入、持有還是賣出?
根據分析師評級,Translational Development Acquisition Corp(TDACU)的總體評級為--,目標價格為--。
Translational Development Acquisition Corp(TDACU)股票的每股收益(EPS TTM)是多少
Translational Development Acquisition Corp(TDACU)股票的每股收益(EPS TTM)是--。